Cargando…
Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates
Pseudomonas aeruginosa is an opportunistic pathogen and a major driver of morbidity and mortality in people with Cystic Fibrosis (CF). The Type VI secretion system (T6SS) is a molecular nanomachine that translocates effectors across the bacterial membrane into target cells or the extracellular envir...
Autores principales: | Robinson, Luca A., Collins, Alice C. Z., Murphy, Ronan A., Davies, Jane C., Allsopp, Luke P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846239/ https://www.ncbi.nlm.nih.gov/pubmed/36687572 http://dx.doi.org/10.3389/fmicb.2022.1042505 |
Ejemplares similares
-
Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System
por: Jones, Cerith, et al.
Publicado: (2013) -
Structure-Based Prototype Peptides Targeting the Pseudomonas aeruginosa Type VI Secretion System Effector as a Novel Antibacterial Strategy
por: Gao, Xiaopan, et al.
Publicado: (2017) -
A Type VI Secretion System Trans-Kingdom Effector Is Required for the Delivery of a Novel Antibacterial Toxin in Pseudomonas aeruginosa
por: Berni, Benjamin, et al.
Publicado: (2019) -
Type VI Secretion System in Pseudomonas aeruginosa: SECRETION AND MULTIMERIZATION OF VgrG PROTEINS
por: Hachani, Abderrahman, et al.
Publicado: (2011) -
RpoN/Sfa2-dependent activation of the Pseudomonas
aeruginosa H2-T6SS and its cognate arsenal of antibacterial
toxins
por: Allsopp, Luke P, et al.
Publicado: (2021)